EV Biologics (EV Biologics) EBITDA Margin % : -3.73% (As of Dec. 2017)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. EV Biologics's EBITDA for the three months ended in Dec. 2017 was $-1.45 Mil. EV Biologics's Revenue for the three months ended in Dec. 2017 was $38.72 Mil. Therefore, EV Biologics's EBITDA margin for the quarter that ended in Dec. 2017 was -3.73%.

EV Biologics EBITDA Margin % Historical Data

The historical data trend for EV Biologics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics EBITDA Margin % Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

EBITDA Margin %

35.69

37.17

31.64

-109.24

-61.19

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
EBITDA Margin %	Get a 7-Day Free Trial												-1,095.29	-84.38	-112.91	-	-3.73

Competitive Comparison of EV Biologics's EBITDA Margin %

For the Biotechnology subindustry, EV Biologics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EV Biologics's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EV Biologics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where EV Biologics's EBITDA Margin % falls into.

EV Biologics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

EV Biologics's EBITDA Margin % for the fiscal year that ended in Jun. 2017 is calculated as

EBITDA Margin %	=	EBITDA (A: Jun. 2017 )	/	Revenue (A: Jun. 2017 )
	=	-5.817	/	9.507
	=	-61.19 %

EV Biologics's EBITDA Margin % for the quarter that ended in Dec. 2017 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2017 )	/	Revenue (Q: Dec. 2017 )
	=	-1.445	/	38.723
	=	-3.73 %

EV Biologics (OTCPK:YECO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

EV Biologics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of EV Biologics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » EBITDA Margin %

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3